Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations With Statin Therapy: A Systematic Review
DOI:
https://doi.org/10.56570/jimgs.v2i2.137Keywords:
COPD, statins, inflammation, chronicmobstructive pulmonary disease exacerbations, emphysema, albuterolAbstract
This systematic review focuses on examining the treatment of chronic obstructive pulmonary disease (COPD) and preventing exacerbations. Despite the pharmacological interventions available, chronic obstructive pulmonary disease (COPD) is not curable. The goal of treatment in chronic obstructive pulmonary disease (COPD) patients is more focused on providing relief of symptoms such as dyspnea and shortness of breath. The purpose is to review the efficacy of daily Statin use in patients with newly diagnosed chronic obstructive pulmonary disease (COPD). This systematic review follows the Preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines 2020 and a search strategy was conducted using a variety of reputable databases such as PubMed, Google Scholar, Science Direct, and Research Gate. Of the 595 studies identified based on the selection of databases, 10 were selected for the final inclusion in the study. This review also highlights chronic obstructive pulmonary disease (COPD) pathophysiology, diagnosis, and treatment. The review provides a discussion section that demonstrated the outcomes of chronic obstructive pulmonary disease (COPD) exacerbations in patients on a daily regimen of Statins.References
Ajmera M, Shen C, Sambamoorthi, U: Association Between Statin Medications and COPD-Specific Outcomes: A Real-World Observational Study. Drugs Real World Outcomes. 2017, 4:9-19. 10.1007/s40801-016-0101-6
Criner GJ, Connett JE, Aaron SD, et al.: Simvastatin for the Prevention of Exacerbations in Moderate-to-Severe COPD. N Engl J Med. 2014, 370:2201–10. 10.1056/nejmoa1403086
Freyberg J, Landt EM, Afzal S, Nordestgaard BG, Dahl M: Low-density lipoprotein cholesterol and risk of COPD: Copenhagen General Population Study. ERJ Open Res. 2022, 9:00496–2022. 10.1183/23120541.00496-2022
Soyseth V, Brekke PH, Smith P, Omland T: Statin use is associated with reduced mortality in COPD. European Respiratory Journal. 2006, 29:279–83. 10.1183/09031936.00106406
Mortensen EM, Copeland LA, Pugh MJV, Restrepo MI, de Molina RM, Nakashima B, Anzueto A: Impact of statins and ACE inhibitors on mortality after COPD exacerbations. Respir Res. 2009, 10:. 10.1186/1465-9921-10-45
Zhang W, Zhang Y, Li C-W, Jones P, Wang C, Fan Y: Effect of Statins on COPD. Chest. 2017, 152:1159–68. 10.1016/j.chest.2017.08.015
Maneechotesuwan K, Wongkajornsilp A, Adcock I, et al.: Simvastatin Suppresses Airway IL-17 and Upregulates IL-10 in Patients With Stable COPD. 2015, 2015:1164-1176. 10.1378/chest.14-3138
Raymakers AJN, Sadatsafavi M, Sin DD, De Vera MA, Lynd LD: The Impact of Statin Drug Use on All-Cause Mortality in Patients With COPD. Chest. 2017, 152:486–93. 10.1016/j.chest.2017.02.002
Rossi A, Inciardi RM, Rossi A, et al.: Prognostic effects of rosuvastatin in patients with co-existing chronic obstructive pulmonary disease and chronic heart failure: A sub-analysis of GISSI-HF trial. Pulmonary Pharmacology & Therapeutics. 2017, 44:16–23. 10.1016/j.pupt.2017.03.001
Balaguer C, Peralta A, Ríos Á, et al.: Effects of simvastatin in chronic obstructive pulmonary disease: Results of a pilot, randomized, placebo-controlled clinical trial. Contemporary Clinical Trials Communications. 2016, 2:91–6. 10.1016/j.conctc.2015.12.008
Page MJ, McKenzie JE, Bossuyt PM, et al.: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021, 10.1186/s13643-021-01626-4
Petty TL: The history of COPD. International Journal of COPD. 2006, 1:3–14. 10.2147/copd.2006.1.1.3
Fortis S, Quibrera PM, Comellas AP, et al.: Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD. Chest. 2023, 163:502–14. 10.1016/j.chest.2022.11.009
Wang M-T, Lo Y-W, Tsai C-L, Chang L-C, Malone DC, Chu C-L, Liou J-T: Statin Use and Risk of COPD Exacerbation Requiring Hospitalization. The American Journal of Medicine. 2013, 126:598-606.e2. 10.1016/j.amjmed.2013.01.036
Fehrenbach H: Respir Res. 2001, 2:33. 10.1186/rr36
Brandt J, Mandiga P: Histology, Alveolar Cells. 2023. https://www.ncbi.nlm.nih.gov/books/NBK557542.
Meyer M, Jaspers I: Respiratory protease/antiprotease balance determines susceptibility to viral infection and can be modified by nutritional antioxidants. American Journal of Physiology-Lung Cellular and Molecular Physiology. 2015, 308:L1189–201. 10.1152/ajplung.00028.2015
Johns D, Walters J, Walters H: Diagnosis and early detection of COPD using spirometry. 2014, 6:10.3978/j.issn.2072-1439.2014.08.18
Di Stefano A, Caramori G, Ricciardolo FLM, Capelli A, Adcock IM, Donner CF: Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview. Clin Exp Allergy. 2004, 34:1156–67. 10.1111/j.1365-2222.2004.02030.x
Qureshi H, Sharafkhaneh A, Hanania NA: Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications. Therapeutic Advances in Chronic Disease. 2014, 5:212–27. 10.1177/2040622314532862
Bollmeier SG, Hartmann AP: Management of chronic obstructive pulmonary disease: A review focusing on exacerbations. American Journal of Health-System Pharmacy. 2020, 77:259–68. 10.1093/ajhp/zxz306
Ucgun I, Metintas M, Moral H, Alatas F, Yildirim H, Erginel S: Predictors of hospital outcome and intubation in COPD patients admitted to the respiratory ICU for acute hypercapnic respiratory failure. Respiratory Medicine. 2006, 100:66–74. 10.1016/j.rmed.2005.04.005
Mani RK, Schmidt W, Lund LW, Herth FJF: Respiratory Dialysis for Avoidance of Intubation in Acute Exacerbation of COPD. ASAIO Journal. 2013, 59:675–8. 10.1097/mat.0000000000000004
Lu Y, Chang R, Yao J, Xu X, Teng Y, Cheng N: Effectiveness of long-term using statins in COPD – a network meta-analysis. Respir Res. 2019, 20:. 10.1186/s12931-019-0984-3
Jain MK, Ridker PM: Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms. Nat Rev Drug Discov. 2005, 4:977–87. 10.1038/nrd1901
Damkjaer M, Håkansson K, Kallemose T, Ulrik CS, Godtfredsen N: Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality – The STATUETTE Cohort Study. COPD. 2021, Volume 16:579–89. 10.2147/copd.s296472
Ingebrigtsen TS, Marott JL, Nordestgaard BG, Lange P, Hallas J, Vestbo J: Statin use and exacerbations in individuals with chronic obstructive pulmonary disease. Thorax. 2014, 70:33–40. 10.1136/thoraxjnl-2014-205795
Diamantis E, Kyriakos G, Quiles-Sanchez LV, Farmaki P, Troupis T: The Anti-Inflammatory Effects of Statins on Coronary Artery Disease: An Updated Review of the Literature. CCR. 2017, 13:. 10.2174/1573403x13666170426104611
Graf J, Jörres RA, Lucke T, Nowak D, Vogelmeier CF, Ficker JH: Medical Treatment of COPD. Deutsches Ärzteblatt international. 2018. 10.3238/arztebl.2018.0599
Mathioudakis AG, Vestbo J, Singh D: Long-Acting Bronchodilators for Chronic Obstructive Pulmonary Disease. Clinics in Chest Medicine. 2020, 41:463–74. 10.1016/j.ccm.2020.05.005
Rabbat A, Guetta A, Lorut C, Lefebvre A, Roche N, Huchon G: Prise en charge des exacerbations aiguës de BPCO. Revue des Maladies Respiratoires. 2010, 27:939–53. 10.1016/j.rmr.2010.08.003
Wildman MJ, O’Dea J, Kostopoulou O, Tindall M, Walia S, Khan Z: Variation in intubation decisions for patients with chronic obstructive pulmonary disease in one critical care network. QJM: An International Journal of Medicine. 2003, 96:583–91. 10.1093/qjmed/hcg104
Ferrera MC, Labaki WW, Han MK: Advances in Chronic Obstructive Pulmonary Disease. Annu. Rev. Med. 2021, 72:119–34. 10.1146/annurev-med-080919-112707
Yayan J, Bald M, Franke K-J: No Independent Influence of Statins on the Chronic Obstructive Pulmonary Disease Exacerbation Rate: A Cohort Observation Study Over 10 Years. IJGM. 2021, Volume 14:2883–92. 10.2147/ijgm.s309647
Barnes PJ: Alveolar Macrophages as Orchestrators of COPD. COPD: Journal of Chronic Obstructive Pulmonary Disease. 2004, 1:59–70. 10.1081/copd-120028701
